Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I6EH
|
||||
| Former ID |
DNC013866
|
||||
| Drug Name |
Cudraxanthone D
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530017] | ||
| Formula |
C24H26O6
|
||||
| Canonical SMILES |
CC(=CCC1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=CC(=C3C(C)(C)C=C)<br />OC)O)C
|
||||
| InChI |
1S/C24H26O6/c1-7-24(4,5)20-17(29-6)10-14(25)19-22(28)18-13(9-8-12(2)3)21(27)15(26)11-16(18)30-23(19)20/h7-8,10-11,25-27H,1,9H2,2-6H3
|
||||
| InChIKey |
UIIGEZZURHDEDK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530017] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||